Noninvasive Models to Assess Liver Inflammation and Fibrosis in Chronic HBV Infected Patients with Normal or Mildly Elevated Alanine Transaminase Levels: Which One Is Most Suitable?

Shasha Ma,Lian Zhou,Shutao Lin,Mingna Li,Jing Luo,Lubiao Chen

DOI: https://doi.org/10.3390/diagnostics14050456

IF: 3.6

2024-02-20

Diagnostics

Abstract:The prevalence of substantial inflammation or fibrosis in treatment-naïve patients with chronic hepatitis B (CHB) and normal alanine transaminase (ALT) levels is high. A retrospective analysis was conducted on 559 consecutive patients with hepatitis B virus infection, who underwent liver biopsy, to investigate the value of noninvasive models based on routine serum markers for evaluating liver histology in CHB patients with normal or mildly elevated ALT levels and to provide treatment guidance. After comparing 55 models, we identified the top three models that exhibited excellent performance. The APGA model, based on the area under the receiver operating characteristic curve (AUROC), demonstrated a superior ability to evaluate significant (AUROC = 0.750) and advanced fibrosis (AUROC = 0.832) and demonstrated a good performance in assessing liver inflammation (AUROCs = 0.779 and 0.874 for stages G ≥ 2 and G ≥ 3, respectively). APGA also exhibited significant correlations with liver inflammation and fibrosis stage (correlation coefficients, 0.452 and 0.405, respectively (p < 0.001)). When the patients were stratified into groups based on HBeAg status and ALT level, APGA consistently outperformed the other 54 models. The other top two models, GAPI and XIE, also outperformed models based on other chronic hepatitis diseases. APGA may be the most suitable option for detecting liver fibrosis and inflammation in Chinese patients with CHB.

medicine, general & internal

What problem does this paper attempt to address?

This paper aims to solve the problem of selecting non - invasive models for evaluating liver inflammation and fibrosis in patients with chronic hepatitis B (CHB) when alanine aminotransferase (ALT) levels are normal or slightly elevated. Specifically, the study retrospectively analyzed the clinical data of 559 hepatitis B virus - infected patients who underwent liver biopsy, compared 55 non - invasive models based on routine serum markers to evaluate the accuracy of these models in diagnosing liver inflammation and fibrosis in CHB patients and provide treatment guidance. The study finally identified the three best - performing models. Among them, the APGA model performed excellently in evaluating significant fibrosis (AUROC = 0.750) and advanced fibrosis (AUROC = 0.832), and also showed good performance in evaluating liver inflammation (AUROCs were 0.779 and 0.874 respectively). In addition, when patients were stratified according to HBeAg status and ALT levels, the performance of the APGA model was always better than the other 54 models. Therefore, the APGA model may be the most appropriate option for detecting liver fibrosis and inflammation in Chinese CHB patients.